BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDY

Abrams, 2002, Neurourol Urodyn, 21, 167, 10.1002/nau.10052

Jackson, 1997, Urology, 50, 18, 10.1016/S0090-4295(97)00580-3

Chapple, 2000, Urology, 55, 33, 10.1016/S0090-4295(99)00492-6

Andersson, 2004, Urology, 63, 32, 10.1016/j.urology.2003.10.005

Chartier-Kastler, 2000, Spinal Cord, 38, 490, 10.1038/sj.sc.3101033

Reitz, 2004, Eur Urol, 45, 510, 10.1016/j.eururo.2003.12.004

Schurch, 2000, J Urol, 164, 692, 10.1016/S0022-5347(05)67283-7

Dolly, 2003, Headache, 43, S16, 10.1046/j.1526-4610.43.7s.4.x

Fowler, 2002, Urology, 59, 37, 10.1016/S0090-4295(02)01544-3

Stohrer, 1999, Neurourol Urodyn, 18, 139, 10.1002/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U

Abrams, 1988, Scand J Urol Nephrol Suppl, 114, 5

Hatheway, 1994, 93

Wagner, 1996, Urology, 47, 67, 10.1016/S0090-4295(99)80384-7

Foley, 1997, Br J Urol, 79, 888, 10.1046/j.1464-410X.1997.00191.x

Bakke, 1997, Br J Urol, 79, 85, 10.1046/j.1464-410X.1997.30018.x

Jankovic, 2003, Neurology, 60, 1186, 10.1212/01.WNL.0000055087.96356.BB